Fetal Growth Restriction: Surveillance and Delivery Timing

Fetal growth restriction (FGR) describes a fetus that has failed to reach its biological growth potential, often because of placental insufficiency. It is different from a constitutionally small fetus, which may be healthy and appropriately developed for its genetic background. Distinguishing these conditions is central to decisions about monitoring, counseling, and birth.

The clinical problem is rarely solved by a single ultrasound measurement. Estimated fetal weight, abdominal circumference, growth trajectory, amniotic fluid, umbilical artery Doppler, maternal disease, gestational age, and fetal well-being must be interpreted together. A careful plan aims to avoid both stillbirth and the complications of unnecessary prematurity.

Surveillance should therefore be dynamic. A reassuring assessment today does not guarantee that placental function will remain stable, while an abnormal Doppler result does not automatically dictate immediate delivery in every pregnancy. Timing depends on the severity and pattern of compromise, the available neonatal support, and the ability to perform reliable follow-up.

Why Fetal Growth Restriction Matters

FGR is commonly identified when estimated fetal weight (EFW) or abdominal circumference falls below the 10th percentile for gestational age. More severe disease is often associated with an EFW below the third percentile, abnormal blood-flow studies, reduced amniotic fluid, or a slowing growth trajectory. Percentile thresholds are useful screening tools, but they should not replace clinical interpretation.

Placental insufficiency can reduce the supply of oxygen and nutrients, leading to adaptive changes in fetal circulation. The fetus may redistribute blood flow toward the brain, heart, and adrenal glands while reducing perfusion to other organs. As the condition progresses, venous and cardiac findings may become abnormal, signaling a higher risk of acidosis and stillbirth.

The causes are diverse. Hypertensive disorders, preeclampsia, renal disease, autoimmune disease, smoking, malnutrition, infection, fetal chromosomal conditions, structural abnormalities, and placental pathology can all contribute. Some cases remain unexplained. The evaluation should look for a pattern rather than assume that every small fetus has the same underlying mechanism or prognosis.

Establishing The Diagnosis

Accurate dating is the foundation of growth assessment. An incorrect gestational age can make a normally growing fetus appear small or conceal genuine growth restriction. First-trimester crown-rump length is generally the most reliable method for establishing gestational age, while later redating should be approached cautiously.

Ultrasound should assess fetal biometry, anatomy, placental location, and amniotic fluid. EFW is calculated from measurements such as head circumference, abdominal circumference, and femur length, but each measurement carries technical and biological uncertainty. A single low percentile deserves confirmation and context, particularly when the anatomy, fluid volume, and Doppler findings are reassuring.

Serial scans are more informative than measurements taken too close together. In many pregnancies, a repeat growth assessment after roughly two to four weeks allows enough time to detect a meaningful change, although the interval should be individualized. A persistently small abdominal circumference with falling growth velocity is more concerning than stable measurements in an otherwise healthy fetus.

Early-onset FGR, diagnosed well before term, is more likely to be associated with severe placental disease, fetal anomalies, or genetic conditions. Late-onset FGR may be subtler and can occur with normal or only mildly abnormal umbilical artery flow. Both forms matter: late gestation does not eliminate the risk of fetal intolerance or stillbirth.

Building A Reliable Surveillance Plan

Umbilical artery Doppler is a central tool in suspected placental insufficiency. Increased resistance, absent end-diastolic flow, and reversed end-diastolic flow represent progressively more concerning patterns. The frequency of testing should increase when flow becomes abnormal, fetal growth is very low, or maternal disease is worsening.

Middle cerebral artery Doppler can help identify fetal cerebral blood-flow redistribution, particularly in late-onset FGR. The cerebroplacental ratio, which relates cerebral and placental resistance, may add information in selected cases. However, interpretation depends on gestational age, reference standards, equipment, and local expertise. It should complement rather than replace clinical assessment.

Cardiotocography or nonstress testing evaluates fetal heart-rate behavior, while the biophysical profile combines ultrasound observations with heart-rate assessment. These tests can provide valuable short-term information, but a normal result does not erase an abnormal Doppler pattern or a concerning maternal condition. Venous Doppler, especially ductus venosus assessment, may be important in early severe FGR managed in specialist units.

Surveillance also includes maternal symptoms and examination. New headache, visual disturbance, epigastric pain, sudden swelling, elevated blood pressure, or laboratory evidence of preeclampsia can change the delivery plan quickly. Reduced fetal movement requires urgent assessment rather than waiting for the next scheduled scan.

These categories are not a substitute for local protocols. Doppler thresholds, testing intervals, and delivery recommendations vary among professional bodies and depend on the gestational age at diagnosis. The table is best used as a framework for discussion rather than an automatic decision pathway.

Selecting The Timing Of Birth

The timing of delivery balances two competing risks: continued exposure to placental insufficiency and harm from prematurity. At earlier gestations, prolonging pregnancy may allow maturation and improve neonatal outcomes, provided surveillance remains reassuring. At later gestations, the advantages of continuing the pregnancy often diminish as the risk of fetal compromise rises.

For isolated smallness with normal fluid, normal fetal testing, and normal umbilical artery flow, expectant management toward term is often reasonable. When growth is severely reduced or resistance in the umbilical artery is elevated, delivery is generally considered earlier. Absent or reversed end-diastolic flow usually calls for intensified surveillance, consultation with a tertiary center, and a carefully prepared birth plan.

Gestational age alone cannot determine the decision. Persistent abnormal cardiotocography, deteriorating venous Doppler, oligohydramnios, severe maternal hypertension, preeclampsia, bleeding, or reduced fetal movement may require delivery before a planned milestone. Conversely, an isolated borderline measurement with reassuring longitudinal growth should not automatically trigger preterm birth.

Before anticipated preterm delivery, antenatal corticosteroids should be considered according to gestational age and local guidance. Magnesium sulfate may be recommended for fetal neuroprotection at very early gestations. The neonatal team should be involved before delivery, particularly when birth may occur before term or when absent or reversed flow suggests a high likelihood of respiratory, metabolic, or circulatory support.

Considering Maternal And Fetal Context

Maternal health can influence both the development of FGR and the safety of continuing pregnancy. Blood-pressure control, urine protein assessment, renal and liver testing, medication review, nutritional evaluation, and screening for relevant infections may be appropriate. Aspirin may reduce the risk of preeclampsia and placental disease in selected high-risk patients when started at the recommended time, but it is not a treatment for established severe FGR.

Psychological stress deserves a compassionate and evidence-informed discussion. Stress is not a simple standalone cause of poor fetal growth, and blaming a pregnant patient can damage care. Still, sleep disruption, anxiety, depression, financial insecurity, violence, and chronic stress may affect health behaviors, blood pressure, access to care, and overall pregnancy well-being. Research on maternal stress and fetal development reinforces the value of supportive, nonjudgmental care.

The COVID-19 pandemic also demonstrated how interruptions in prenatal visits, restricted travel, staff shortages, and unequal access to emergency obstetric services can affect perinatal outcomes. Evidence summarized in discussions of global perinatal mortality highlights the importance of resilient referral pathways and continuity of monitoring during public-health emergencies.

Fetal diagnosis and prognosis must be considered alongside parental values. Families should receive clear information about uncertainty, possible neonatal outcomes, the reason for each test, and signs that require immediate presentation. Shared decision-making is especially important when clinicians are choosing between prolonged surveillance and delivery at the edge of viability or prematurity.

Practical Recommendations For Care Teams

A consistent pathway reduces missed deterioration and prevents isolated test results from driving care without context. Documentation should make clear the estimated due date, severity category, Doppler pattern, testing schedule, maternal risks, escalation triggers, and location planned for birth.

Patients should know how to contact the maternity unit at any hour and should receive specific instructions about fetal movement, bleeding, fluid leakage, contractions, severe headache, visual changes, and upper abdominal pain. Care teams should also confirm that follow-up appointments and transport are realistic, since a surveillance plan is only effective when it can be completed.

• Confirm gestational age and review the full ultrasound picture rather than relying on EFW alone.
• Use serial growth assessment and Doppler studies to identify trajectory and placental deterioration.
• Increase surveillance when growth is severe, Doppler findings are abnormal, or maternal disease progresses.
• Involve maternal-fetal medicine, neonatology, and anesthesia early when preterm birth is possible.
• Give families a written escalation plan, including reduced fetal movement and symptoms of preeclampsia.

The best results come from linking measurement to action. An ultrasound report should lead to a defined follow-up interval, a responsible clinician, and a clear threshold for reassessment or delivery. Hospitals can strengthen care by auditing stillbirths, preterm births, Doppler interpretation, referral delays, and neonatal outcomes.

Clinicians and service leaders can use these principles to review local FGR protocols, align them with current professional guidance, and ensure that families receive timely surveillance and a well-prepared delivery when fetal or maternal risk makes birth the safer choice.